Who owns Anavex Life Sciences Corp.?
Institutional ownership of AVXL from SEC Form 13F filings across 137 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
137
13F holders
$85.0M
value, 2026 filers
35.5%
of shares outstanding (32.9M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of AVXL's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 8.1M | $20.9M | 0.0% | 8.7% | +5.9% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4.1M | $10.5M | 0.0% | 4.4% | -47.5% |
| 3 | TWO SIGMA INVESTMENTS, LP | 3.0M | $7.9M | 0.0% | 3.3% | -6.2% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $6.2M | 0.0% | 2.6% | +10.0% |
| 5 | FEDERATED HERMES, INC. | 1.1M | $2.8M | 0.0% | 1.2% | +101.4% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 948,633 | $2.5M | 0.0% | 1% | +21.1% |
| 7 | Summit Financial, LLC | 909,430 | $2.4M | 0.0% | 1% | -3.3% |
| 8 | GOLDMAN SACHS GROUP INC | 890,634 | $2.3M | 0.0% | 1% | +10.7% |
| 9 | MARSHALL WACE, LLP | 889,523 | $2.3M | 0.0% | 1% | +112.0% |
| 10 | NORTHERN TRUST CORP | 784,494 | $2.0M | 0.0% | 0.8% | +8.2% |
| 11 | BARCLAYS PLC | 754,226 | $2.0M | 0.0% | 0.8% | +40.1% |
| 12 | Sixth Street Partners Management Company, L.P.NEW | 734,795 | $1.9M | 0.3% | 0.8% | new |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 734,795 | $1.9M | 0.0% | 0.8% | -2.9% |
| 14 | BANK OF AMERICA CORP /DE/ | 654,295 | $1.7M | 0.0% | 0.7% | -24.2% |
| 15 | VANGUARD FIDUCIARY TRUST CO | 621,451 | $1.6M | 0.0% | 0.7% | -4.0% |
| 16 | UBS Group AG | 620,374 | $1.6M | 0.0% | 0.7% | +8.8% |
| 17 | LPL Financial LLC | 406,109 | $1.1M | 0.0% | 0.4% | -3.0% |
| 18 | STIFEL FINANCIAL CORP | 332,597 | $861,429 | 0.0% | 0.4% | +40.5% |
| 19 | CITADEL ADVISORS LLC | 329,115 | $852,408 | 0.0% | 0.4% | -41.2% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 319,529 | $827,580 | 0.0% | 0.3% | -67.9% |
| 21 | Bank of New York Mellon Corp | 288,199 | $746,435 | 0.0% | 0.3% | +16.3% |
| 22 | Apella Capital, LLC | 227,995 | $617,866 | 0.0% | 0.2% | +49.0% |
| 23 | MORGAN STANLEY | 194,963 | $504,955 | 0.0% | 0.2% | -45.5% |
| 24 | Nuveen, LLC | 182,722 | $473,249 | 0.0% | 0.2% | +8.0% |
| 25 | Point72 Asset Management, L.P.NEW | 157,486 | $407,889 | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.